IRGM1 enhances B16 melanoma cell metastasis through PI3K-Rac1 mediated epithelial mesenchymal transition

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Tian, Linlu ^a   Li, Lixian ^a   Xing, Wenjing ^a   Li, Rui ^b   Pei, Chunying ^a   Dong, Xiao ^a   Fu, Yanran ^a   Gu, Changcong ^a   Guo, Xize ^a   Jia, Yulong ^a   Wang, Guangyou ^a   Wang, Jinghua ^a   Li, Bo ^a   Ren, Huan ^a   Xu, Hongwei ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; IFI1 PROTEIN, MOUSE; NEUROPEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; RAC1 PROTEIN; RAC1 PROTEIN, MOUSE;

ANIMAL; C57BL MOUSE; EPITHELIAL MESENCHYMAL TRANSITION; LUNG TUMOR; MELANOMA; METABOLISM; MOUSE; PATHOLOGY; SECONDARY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GTP-BINDING PROTEINS; LUNG NEOPLASMS; MELANOMA; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEUROPEPTIDES; PHOSPHATIDYLINOSITOL 3-KINASES; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 84937862539     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12357     Document Type: Article

References (36)

1. Miller, A. J., Mihm, Jr. M. C. Melanoma. N Engl J Med 355, 51-65 (2006).
2. Alonso, S. R. et al. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res 67, 3450-60 (2007).
3. Caramel, J. et al. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell 24, 466-80 (2013).
4. MacMicking, J. D., Taylor, G. A., McKinney, J. D. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 302, 654-9 (2003).
5. Feng, C. G. et al. The immunity-related GTPase Irgm1 promotes the expansion of activated CD4+ T cell populations by preventing interferon-gamma-induced cell death. Nat Immunol 9, 1279-87 (2008).
6. Xu, H. et al. Genetic deficiency of Irgm1 (LRG-47) suppresses induction of experimental autoimmune encephalomyelitis by promoting apoptosis of activated CD4+ T cells. FASEB J 24, 1583-92 (2010).
7. King, K. Y. et al. Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling. Blood 118, 1525-33 (2011).
8. He, S. et al. Immune-related GTPase M (IRGM1) regulates neuronal autophagy in a mouse model of stroke. Autophagy 8, 1621-7 (2012).
9. Dong, H. et al. IFNg-induced Irgm1 promotes tumorigenesis of melanoma via dual regulation of apoptosis and Bif-1-dependent autophagy. Oncogene (2015).
10. Henry, S. C. et al. Regulation of macrophage motility by Irgm1. J Leukoc Biol 87, 333-43 (2010).
11. Xia, F. et al. IRGM1 regulates oxidized LDL uptake by macrophage via actin-dependent receptor internalization during atherosclerosis. Sci Rep 3, 1867 (2013).
12. Boyer, B., Valles, A. M., Edme, N. Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 60, 1091-9 (2000).
13. Larue, L., Bellacosa, A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene 24, 7443-54 (2005).
14. Zeisberg, M., Neilson, E. G. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119, 1429-37 (2009).
15. Kalluri, R., Weinberg, R. A. The basics of epithelial-mesenchymal transition. J Clin Invest 119, 1420-8 (2009).
16. Parri, M., Chiarugi, P. Rac and Rho GTPases in cancer cell motility control. Cell Commun Signal 8, 23 (2010).
17. Monaghan-Benson, E., Burridge, K. Mutant B-RAF regulates a Rac-dependent cadherin switch in melanoma. Oncogene 32, 4836-44 (2013).
18. Tiwari, S., Choi, H. P., Matsuzawa, T., Pypaert, M., MacMicking, J. D. Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3, 4)P(2) and PtdIns(3, 4, 5)P(3) promotes immunity to mycobacteria. Nat Immunol 10, 907-17 (2009).
19. Cain, R. J., Vanhaesebroeck, B., Ridley, A. J. The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. J Cell Biol 188, 863-76 (2010).
20. Shin, D. H., Kim, O. H., Jun, H. S., Kang, M. K. Inhibitory effect of capsaicin on B16-F10 melanoma cell migration via the phosphatidylinositol 3-kinase/Akt/Rac1 signal pathway. Exp Mol Med 40, 486-94 (2008).
21. Zhang, L. J., Tao, B. B., Wang, M. J., Jin, H. M., Zhu, Y. C. PI3K p110alpha isoform-dependent Rho GTPase Rac1 activation mediates H2S-promoted endothelial cell migration via actin cytoskeleton reorganization. PLoS One 7, e44590 (2012).
22. Wan, L., Pantel, K., Kang, Y. Tumor metastasis: moving new biological insights into the clinic. Nat Med 19, 1450-64 (2013).
23. Zhang, P. et al. C6-ceramide nanoliposome suppresses tumor metastasis by eliciting PI3K and PKCzeta tumor-suppressive activities and regulating integrin affinity modulation. Sci Rep 5, 9275 (2015).
24. Schlegel, N. C., von Planta, A., Widmer, D. S., Dummer, R., Christofori, G. PI3K signalling is required for a TGFbeta-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells. Exp Dermatol 24, 22-8 (2015).
25. Kallergi, G., Agelaki, S., Markomanolaki, H., Georgoulias, V., Stournaras, C. Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells. Cell Physiol Biochem 20, 977-86 (2007).
26. Ebi, H. et al. PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1. Proc Natl Acad Sci USA 110, 21124-9 (2013).
27. Davis, M. J. et al. RAC1P29S is a spontaneously activating cancer-associated GTPase. Proc Natl Acad Sci USA 110, 912-7 (2013).
28. Feng, C. G., Zheng, L., Lenardo, M. J., Sher, A. Interferon-inducible immunity-related GTPase Irgm1 regulates IFN gammadependent host defense, lymphocyte survival and autophagy. Autophagy 5, 232-4 (2009).
29. Singh, S. B., Davis, A. S., Taylor, G. A., Deretic, V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313, 1438-41 (2006).
30. Henry, S. C. et al. Impaired macrophage function underscores susceptibility to Salmonella in mice lacking Irgm1 (LRG-47). J Immunol 179, 6963-72 (2007).
31. Petkova, D. S., Viret, C., Faure, M. IRGM in autophagy and viral infections. Front Immunol 3, 426 (2012).
32. Butcher, B. A. et al. p47 GTPases regulate Toxoplasma gondii survival in activated macrophages. Infect Immun 73, 3278-86 (2005).
33. Mahmoud, M. E., Ui, F., Salman, D., Nishimura, M., Nishikawa, Y. Mechanisms of interferon-beta-induced inhibition of Toxoplasma gondii growth in murine macrophages and embryonic fibroblasts: role of immunity-related GTPase M1 (IRGM1). Cell Microbiol (2015). doi: 10.1111/cmi.12423
34. Wang, C. et al. Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier. Mol Immunol 53, 43-51 (2013).
35. McCarroll, S. A. et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet 40, 1107-12 (2008).
36. Brest, P. et al. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat Genet 43, 242-5 (2011).